Radiologists and AI researchers reported a high-resolution CT radiomics model that predicts invasiveness in pure ground-glass lung adenocarcinoma. The work, led by Tianjin Chest Hospital, combines radiomics features with a machine-learning approach to distinguish noninvasive lesions from early invasive disease. The study addresses an immediate clinical bottleneck: deciding whether a small, hazy lesion requires intervention versus surveillance. If validated prospectively, such models can support more consistent decision-making and reduce variability in surgical referral timing. For the biotech sector, the broader implication is pipeline-adjacent—diagnostic enrichment and earlier disease classification can impact how targeted therapies and adjuvant strategies are evaluated in early-stage populations.